Question · asked by 1 review
Transarterial embolisation plus radiofrequency ablation vs radiofrequency ablation: Health‐related quality of life
- Population
- people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
- Intervention
- Transarterial embolisation plus radiofrequency ablation
- Comparison
- radiofrequency ablation
- Outcome
- Health‐related quality of life
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Transarterial embolisation plus radiofrequency ablation vs radiofrequency ablation Health‐related quality of life · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery The review found no eligible studies for this question. Management of people with early‐ or very early‐stage hepatocellular carcinoma (2017) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Management of people with early‐ or very early‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.